Skip to main content
. Author manuscript; available in PMC: 2014 Aug 9.
Published in final edited form as: Cancer Lett. 2013 Apr 23;336(1):149–157. doi: 10.1016/j.canlet.2013.04.020

Figure 2.

Figure 2

(A) The cell viability after being treated with PTX+TPGS, PTX+TPGS-NH2, PTX+TPGSCOOH and PTX (DMSO) for 48 h on H460/taxR and KB-8-5 cells, PTX was at a concentration of 5 μM and 50 nM, respectively (n=6). * indicates a significant difference compared to PTX (in DMSO), p <0.05.

(B) The cell viability after being treated with PTX+TPGS, PTX+VE, PTX+TS (VE succinate), PTX+TPD (phosphate disodium salt), PTX+TA (VE acetate) and PTX+VE-NH2 for 48 h on H460/taxR cells and KB-8-5 cells (n=6). * indicates a significant difference compared to PTX (in DMSO), p <0.05, ** indicates a highly significant difference compared to PTX (in DMSO), p <0.01, # indicates a significant difference compared to PTX+VE, p <0.05.